Citigroup’s Aptose Biosciences, Inc. APTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6116 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6064 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 5889 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 5554 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 5600 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 5659 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6540 |
|
|
2022
Q2 | – | Sell |
-4
| Closed | -$1.91K | – | 6830 |
|
|
2022
Q1 | $3K | Buy |
+4
| New | +$2.21K | ﹤0.01% | 6014 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6443 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6504 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7682 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7699 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 7652 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 7735 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 7832 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7855 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 7865 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 7889 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 7871 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 7884 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 7911 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7790 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 7720 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 7690 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 7512 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 7536 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 7388 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 7371 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 7243 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 7541 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 7862 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 7952 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 7829 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 7832 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 7505 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 7383 |
|
Other funds holding APTO
BL
SPC
FDCDDQ
GG
NFSG
Citigroup's APTO Position: Q1 2025 in Review
Citigroup held its Aptose Biosciences, Inc. (APTO) position steady in Q1 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #6116.
Citigroup first reported a position in APTO in Q1 2022 and has held it in 1 quarter since. The position peaked at $3K in Q1 2022. 16 funds tracked by Wall St. Rank hold APTO as of Q1 2025.
- Citigroup held 0 shares of Aptose Biosciences, Inc. worth $0 as of Q1 2025.
- Citigroup left its Aptose Biosciences, Inc. share count unchanged in Q1 2025.
- Aptose Biosciences, Inc. made up ﹤0.01% of Citigroup's portfolio in Q1 2025, its #6116 holding.
- Citigroup first reported a position in Aptose Biosciences, Inc. in Q1 2022 and has held it in 1 quarter since.
- Citigroup's Aptose Biosciences, Inc. position peaked at $3K in Q1 2022.
- 16 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2025.
Based on Citigroup's 13F filing for Q1 2025, filed 12 May 2025.